(Q54549246)

31 May 2018

title

Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors. (English)

1 reference

31 May 2018

author name string

J Hasenkamp

1

1 reference

31 May 2018

A Borgerding

2

1 reference

31 May 2018

M Uhrberg

3

1 reference

31 May 2018

C Falk

4

1 reference

31 May 2018

B Chapuy

5

1 reference

31 May 2018

G Wulf

6

1 reference

31 May 2018

W Jung

7

1 reference

31 May 2018

L Trümper

8

1 reference

31 May 2018

B Glass

9

1 reference

31 May 2018

publication date

22 January 2008

1 reference

31 May 2018

Scandinavian Journal of Immunology

published in

1 reference

31 May 2018

volume

67

1 reference

31 May 2018

page(s)

218-229

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

1 reference

What is a natural killer cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

The role of CD94/NKG2 in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

NK cells, MHC class I molecules and the missing self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Putting the natural killer cell in its place.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Surface NK receptors and their ligands on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Immune functions encoded by the natural killer gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Licensing of natural killer cells by host major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Self-tolerance of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

How do natural killer cells find self to achieve tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Human NK cell education by inhibitory receptors for MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Human diversity in killer cell inhibitory receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Resistance against natural killer cell cytotoxicity: analysis of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Determinants of antileukemia effects of allogeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.02058.X

10.1111/J.1365-3083.2007.02058.X

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

PubMed ID

18226015

1 reference

31 May 2018